Showing results (171-180 of 209) with videos related to

Sort By:
Pageof 21
Oncotarget|September 2, 2016
Characterizing and targeting PDGFRA alterations in pediatric high-grade gliomaCarl Koschmann, Daniel Zamler, Alan MacKay, et al.
Frontiers in Oncology|June 25, 2021
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated TherapiesMaria B Garcia-Fabiani, Santiago Haase, Andrea Comba, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 30, 2010
Gene therapy-mediated delivery of targeted cytotoxins for glioma therapeuticsMarianela Candolfi, Weidong Xiong, Kader Yagiz, et al.
Plos Medicine|January 16, 2009
HMGB1 mediates endogenous TLR2 activation and brain tumor regressionJames F Curtin, Naiyou Liu, Marianela Candolfi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 3, 2009
Release of HMGB1 in response to proapoptotic glioma killing strategies: efficacy and neurotoxicityMarianela Candolfi, Kader Yagiz, David Foulad, et al.
Toxicology and Applied Pharmacology|February 14, 2013
Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastomaMariana Puntel, Ghulam Muhammad A K M, Catherine Farrokhi, et al.
Neoplasia (New York, N.Y.)|October 27, 2011
B cells are critical to T-cell-mediated antitumor immunity induced by a combined immune-stimulatory/conditionally cytotoxic therapy for glioblastomaMarianela Candolfi, James F Curtin, Kader Yagiz, et al.
Cancer & Metabolism|April 9, 2024
Purine salvage promotes treatment resistance in H3K27M-mutant diffuse midline gliomaErik R Peterson, Peter Sajjakulnukit, Andrew J Scott, et al.
Nature Communications|June 17, 2026
IDH1-R132H enhances oncolytic HSV-1 therapy by facilitating viral entry and immune activation in gliomaEleni Panagioti, Hunter J Kelley, Alexander L Ling, et al.
Research Square|October 4, 2023
Adaptive rewiring of purine metabolism promotes treatment resistance in H3K27M-mutant diffuse midline gliomaErik R Peterson, Peter Sajjakulnukit, Andrew J Scott, et al.
Pageof 21